Characterization of [3H]idazoxan binding sites on human platelets

Platelets

Volumn 13, Issue 4, 2002, Pages 241-246

  Ruiz, Javier ^a   Barinagarrementeria, Guillermo ^a   Martín Gómez, J Ignacio ^a   Callado, Luis F ^a   Meana, J Javier ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ADRENALIN; ALPHA 2A ADRENERGIC RECEPTOR; EFAROXAN; GUANABENZ; IDAZOXAN; IMIDAZOLINE; RILMENIDINE; SEROTONIN; YOHIMBINE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DRUG RECEPTOR; IMIDAZOLINE RECEPTORS; RECEPTOR, ADRENERGIC, ALPHA 2A; RECEPTOR, ADRENERGIC, ALPHA-2A; TRITIUM;

ARTICLE; BINDING SITE; CHROMAFFIN CELL; DERIVATIZATION; DRUG EFFECT; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE MEMBRANE; BINDING COMPETITION; CHEMISTRY; METABOLISM; RADIOASSAY; THROMBOCYTE;

ADRENERGIC ALPHA-ANTAGONISTS; BINDING SITES; BINDING, COMPETITIVE; BLOOD PLATELETS; HUMANS; IDAZOXAN; RADIOLIGAND ASSAY; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, DRUG; TRITIUM;

EID: 0036077351     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/0953371027000     Document Type: Article

References (40)

1. Heterogeneity of alpha-2 adrenergic receptors
2. 2-adrenergic receptors
3. The effects of alpha-adrenergic agents on human platelet aggregation
4. Human blood platelet alpha adrenoceptor in view of the effects of various imidazol(in)e drugs on aggregation
5. Nonadrenergic imidazoline binding sites on human platelets
6. Novel alpha-2 adrenoceptors primarily responsible for inducing human platelet aggregation
7. Central cardiovascular effects of α-adrenergic drugs: Difference between catecholamines and imidazolines
8. Are there multiple imidazoline binding sites?
9. Imidazoline binding sites. Pharmacological and molecular characteristics
10. Imidazoline receptors: Basic knowledge, recent advances and future prospects for therapy and diagnosis
11. 2-adrenoceptors in the rat brain cortex
12. 2-adrenergic drugs also bind with high affinity to a nonadrenergic site
13. 3H]idazoxan in the human cerebral cortex
14. Expression of non-adrenergic imidazoline sites in chromaffin cells and mitochondrial membranes of bovine adrenal
15. Protein measurement with the folin phenol reagent
16. LIGAND: A versatile computerized approach for characterization of ligand binding system
17. Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC
18. 1-Imidazoline receptors: An update
19. Characterization and autoradiographical localization of non-adrenoceptor binding sites in the rat brain
20. 3H]RX821002 (2-methoxy idazoxan) in the human and rat brains
21. 3H]-idazoxan binding sites
22. 1 imidazoline preferring receptors: Two unique sites mediating natriuresis in the rat
23. 1-imidazoline receptors in rat brain
24. 2 imidazoline binding sites in isolated cells from rabbit kidney proximal tubule
25. 2 sites
26. Heterogeneity of imidazoline binding sites revealed by a cirazoline derivative
27. Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims
28. 2-adrenergic receptors
29. Identification of an imidazoline-guanidinium receptive site in mitochondria from rabbit cerebral cortex
30. 2-adrenoceptor subtypes and a non-adrenoceptor imidazoline binding site in rat kidney
31. 3H]idazoxan label different populations of imidazoline sites on rat kidney
32. 2-receptor density and functional circulatory changes in hypertensives
33. 2-adrenoceptor density in pregnancy-induced hypertensive patients: Effect of epidural analgesia
34. 2-adrenoceptor alterations in patients with essential hypertension
35. 2-adrenoceptor alterations in patients with essential hypertension are normalized after treatment with doxazosin but not propranolol
36. Relationship between arterial blood pressure disturbances α-adrenoceptor density
37. Imidazoline receptors and cardiovascular regulations: A statement
38. Imidazoline receptors: A challenge
39. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine
40. Characterization of brain imidazoline receptors in normotensive and hypertensive rats: Differential regulation by chronic imidazoline drug treatment